Showing results (1161-1170 of 6,669) with videos related to

Sort By:
Pageof 667
Annals of Hematology|August 21, 2016
Incidence of catheter-related thrombosis in acute leukemia patients: a comparative, retrospective study of the safety of peripherally inserted vs. centrally inserted central venous cathetersMohammad Refaei, Bruna Fernandes, Joseph Brandwein, et al.
Annals of Hematology|August 23, 2016
Azacitidine-lenalidomide (ViLen) combination yields a high response rate in higher risk myelodysplastic syndromes (MDS)-ViLen-01 protocolMoshe Mittelman, Kalman Filanovsky, Yishai Ofran, et al.
Annals of Hematology|April 17, 2023
Safety and efficacy of mesenchymal stromal cell therapy for multi-drug-resistant acute and late-acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantationMuzaffer Keklik, Burak Deveci, Serhat Celik, et al.
Annals of Hematology|April 19, 2023
Status of major hemostatic components in the setting of COVID-19: the effect on endothelium, platelets, coagulation factors, fibrinolytic system, and complementMohammad Sayyadi, Saeed Hassani, Mahmood Shams, et al.
Annals of Hematology|April 20, 2023
Effectiveness of biosimilar pegfilgrastim in patients with multiple myeloma after high-dose melphalan and autologous stem cell transplantationMassimo Martino, Mercedes Gori, Gaetana Porto, et al.
Annals of Hematology|April 22, 2021
The time-dependent effects of early-onset Epstein-Barr viremia on adult acute leukemia patients following allo-HSCT with ATG-containing MAC regimenPeng Ke, Xinyou Zhang, Songbai Liu, et al.
Annals of Hematology|April 22, 2021
Treatment patterns and outcomes in real-world transplant-ineligible patients newly diagnosed with multiple myelomaMaría José Cejalvo, Gabriela Bustamante, Esther González, et al.
Annals of Hematology|March 30, 2023
Real-world data from yttrium-90 ibritumomab tiuxetan treatment of relapsed or refractory indolent B-cell non-Hodgkin's lymphoma: J3Zi StudyIlseung Choi, Masaya Okada, Tomoki Ito
Annals of Hematology|April 3, 2023
A randomized controlled trial of thrice-weekly versus thrice-daily oral ferrous fumarate treatment in adult patients with iron-deficiency anemiaSiddhibhong Jongkraijakra, Thitima Doungngern, Warunsuda Sripakdee, et al.
Annals of Hematology|April 23, 2023
Daratumumab with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma patients - real world evidence analysisMartin Stork, Ivan Spicka, Jakub Radocha, et al.
Pageof 667